Xeris Biopharma Holdings (XERS) Market Capitalization (2020 - 2026)
Xeris Biopharma Holdings' Market Capitalization was $1.37 billion in Q2 2026, up 82.6% from $752.92 million a year earlier and up 37.4% from the prior quarter.
Xeris Biopharma Holdings (XERS) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Xeris Biopharma Holdings came in at $1.3 billion, up 157.6% from FY2024.
- Market Capitalization has now increased for three consecutive years, with a five-year compound annual growth rate of 44.1% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $506.57 million in FY2024 (+56.1%), $324.61 million in FY2023 (+79.1%), $181.24 million in FY2022 (-21.7%) and $231.55 million in FY2021 (+10.4%).
- The Q2 2026 figure marks the highest quarterly Market Capitalization in data going back to Q3 2020.
- Compared with a year earlier, Market Capitalization has increased for eight straight quarters, with growth averaging 110.2% over the last eight quarters.
- The best year-over-year quarter for Market Capitalization over five years was Q3 2025 (growth of 217.3%); the worst was Q3 2021 (a decline of 40.5%).
- Per Business Quant data, XERS's Market Capitalization in the three quarters before Q2 2026 was $1 billion (Q1 2026), $1.3 billion (Q4 2025) and $1.35 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.75 Bn |
| Jun 30, 2026 | 1.37 Bn |
| Mar 31, 2026 | 1.00 Bn |
| Dec 31, 2025 | 1.30 Bn |
| Sep 30, 2025 | 1.35 Bn |
| Jun 30, 2025 | 752.92 Mn |
| Mar 31, 2025 | 856.52 Mn |
| Dec 31, 2024 | 506.57 Mn |
| Sep 30, 2024 | 424.66 Mn |
| Jun 30, 2024 | 335.11 Mn |
| Mar 31, 2024 | 327.58 Mn |
| Dec 31, 2023 | 324.61 Mn |
| Sep 30, 2023 | 256.81 Mn |
| Jun 30, 2023 | 361.59 Mn |
| Mar 31, 2023 | 223.78 Mn |
| Dec 31, 2022 | 181.24 Mn |
| Sep 30, 2022 | 212.10 Mn |
| Jun 30, 2022 | 209.37 Mn |
| Mar 31, 2022 | 346.96 Mn |
| Dec 31, 2021 | 231.55 Mn |
Xeris Biopharma Holdings Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=XERS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();